Gilead Sciences (GILD) Other Non-Current Liabilities (2016 - 2025)
Gilead Sciences' Other Non-Current Liabilities history spans 17 years, with the latest figure at $1.2 billion for Q4 2025.
- For Q4 2025, Other Non-Current Liabilities fell 10.04% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, down 10.04%, while the annual FY2025 figure was $1.2 billion, 10.04% down from the prior year.
- Other Non-Current Liabilities reached $1.2 billion in Q4 2025 per GILD's latest filing, up from $866.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $4.8 billion in Q4 2021 to a low of $341.0 million in Q1 2021.
- Average Other Non-Current Liabilities over 5 years is $2.0 billion, with a median of $1.3 billion recorded in 2024.
- The largest YoY upside for Other Non-Current Liabilities was 351.47% in 2021 against a maximum downside of 93.91% in 2021.
- A 5-year view of Other Non-Current Liabilities shows it stood at $4.8 billion in 2021, then decreased by 17.85% to $3.9 billion in 2022, then plummeted by 67.31% to $1.3 billion in 2023, then rose by 1.17% to $1.3 billion in 2024, then decreased by 10.04% to $1.2 billion in 2025.
- Per Business Quant, the three most recent readings for GILD's Other Non-Current Liabilities are $1.2 billion (Q4 2025), $866.0 million (Q3 2025), and $859.0 million (Q2 2025).